A comparison of safety and efficacy of cytotoxic versus molecularly targeted agents in pediatric phase I solid tumor oncology trials
Main Author: | Dorris, Kathleen |
---|---|
Language: | English |
Published: |
University of Cincinnati / OhioLINK
2012
|
Subjects: | |
Online Access: | http://rave.ohiolink.edu/etdc/view?acc_num=ucin1330023465 |
Similar Items
-
Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
by: Bo Qiu, et al.
Published: (2021-06-01) -
World Cancer Day 2021 - Perspectives in Pediatric and Adult Neuro-Oncology
by: Erik P. Sulman, et al.
Published: (2021-05-01) -
Overview of pediatric oncology and hematology in Myanmar
by: Jay Halbert, et al.
Published: (2014-01-01) -
Management of Medical Emergencies in Pediatric Oncology
by: Ahmet Cagri Ciftci, et al.
Published: (2016-09-01) -
Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
by: Hillary Orr, et al.
Published: (2017-08-01)